The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N,4-dibenzhydrylpiperazine-1-carboxamide ID: ALA599217
Max Phase: Preclinical
Molecular Formula: C31H31N3O
Molecular Weight: 461.61
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1
Standard InChI: InChI=1S/C31H31N3O/c35-31(32-29(25-13-5-1-6-14-25)26-15-7-2-8-16-26)34-23-21-33(22-24-34)30(27-17-9-3-10-18-27)28-19-11-4-12-20-28/h1-20,29-30H,21-24H2,(H,32,35)
Standard InChI Key: PPVBMJIAJXVQFX-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
-2.5885 0.8711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7630 0.8711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3546 1.5785 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7630 2.2946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5885 2.2946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0055 1.5785 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8311 1.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2427 2.2922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2407 0.8655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8302 3.0059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2411 3.7203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0676 3.7196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4812 2.9986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0638 2.2871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0659 0.8658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4796 0.1506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0637 -0.5652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2340 -0.5614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8281 0.1543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5290 1.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1153 0.8655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7102 0.8644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1199 0.1483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1219 1.5751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9472 1.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3630 2.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9490 3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1193 2.9989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7114 2.2842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7060 -0.5653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1149 -1.2808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9413 -1.2824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3569 -0.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9415 0.1501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1133 2.2922 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16 17 2 0
1 6 1 0
17 18 1 0
7 9 1 0
18 19 2 0
19 9 1 0
2 3 1 0
3 20 1 0
8 10 2 0
20 21 1 0
3 4 1 0
21 22 1 0
10 11 1 0
22 23 1 0
4 5 1 0
22 24 1 0
11 12 2 0
24 25 2 0
5 6 1 0
25 26 1 0
12 13 1 0
26 27 2 0
27 28 1 0
13 14 2 0
28 29 2 0
29 24 1 0
14 8 1 0
23 30 2 0
6 7 1 0
30 31 1 0
9 15 2 0
31 32 2 0
1 2 1 0
32 33 1 0
15 16 1 0
33 34 2 0
34 23 1 0
7 8 1 0
20 35 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 461.61Molecular Weight (Monoisotopic): 461.2467AlogP: 5.89#Rotatable Bonds: 6Polar Surface Area: 35.58Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 7.26CX LogP: 6.17CX LogD: 5.93Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.39Np Likeness Score: -1.03
References 1. Pajouhesh H, Feng ZP, Ding Y, Zhang L, Pajouhesh H, Morrison JL, Belardetti F, Tringham E, Simonson E, Vanderah TW, Porreca F, Zamponi GW, Mitscher LA, Snutch TP.. (2010) Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors., 20 (4): [PMID:20117000 ] [10.1016/j.bmcl.2010.01.008 ] 2. Zamponi GW, Feng ZP, Zhang L, Pajouhesh H, Ding Y, Belardetti F, Pajouhesh H, Dolphin D, Mitscher LA, Snutch TP.. (2009) Scaffold-based design and synthesis of potent N-type calcium channel blockers., 19 (22): [PMID:19815411 ] [10.1016/j.bmcl.2009.09.008 ]